시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 양 및 염소 수두 백신 시장 보고서(2025년)
Sheep And Goat Pox Vaccines Global Market Report 2025
상품코드 : 1793440
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

양 및 염소 수두 백신 시장 규모는 향후 수년간 안정된 성장이 예상됩니다. 2029년에는 CAGR 4.2%를 나타내 713억 7,000만 달러로 성장할 전망입니다. 예측기간의 성장은 축산물 수요 증가, 축산업 확대, 백신에 대한 정부 보조금, 수의학 연구에 대한 투자 증가, 백신 제조 기술 진보, 동물 건강에 대한 의식 증가, 국제 무역 협정, 질병 패턴에 영향을 미치는 기후 변화, 새로운 백신 기술 출현, 발전도상 지역 경제 성장에 기인합니다. 예측기간의 주요 동향으로는 다가 백신 개발, 재조합 백신 사용 증가, 백신 안전성에 대한 주목 증가, 관민 파트너십 증가, 동물 백신 시장 확대, 백신 접종 프로그램의 디지털 추적, 동물 위생 연구에 대한 자금 제공 증가, 지역적 질병 박멸 이니셔티브, 지속 가능한 농업 관행의 채용 확대, 백신에 관한 규제 틀의 강화 등을 들 수 있습니다.

향후 5년간의 성장률 4.2%라고 하는 예측은 전회의 예측으로부터 0.1%의 미감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 백신의 효능에 필수적인 보조제 및 안정제 관세로 인한 수입 지연은 소형 반추동물의 질병 예방 결과에 영향을 미칠 수 있습니다. 또한 상호관세나 무역마찰·제한의 격화에 의한 세계경제·무역에 대한 악영향에 의해 그 영향은 보다 광범위하게 미칠 것으로 보입니다.

축산물에 대한 수요 증가는 양 및 염소 수두 백신 시장 성장을 견인하게 될 것으로 보입니다. 축산물에는 농업 환경에서 사육된 가축에서 유래한 다양한 상품이 포함됩니다. 이러한 수요 증가는 소득과 인구 증가, 도시화, 건강에 대한 배려, 소비자의 취향의 진화, 세계화, 무역, 경제 개발 등의 요인에 기인하고 있습니다. 양 및 염소 수두 백신은 질병의 발생을 예방하고 양 및 염소의 개체군의 건강과 생산성을 확보함으로써 축산물을 보호하는 중요한 역할을 담당하고 있습니다. 예를 들어 2024년 2월 환경·식품·농촌지역부는 붉은 고기, 특히 양고기와 양고기 생산량 증가를 지적했으며, 최대 증가율은 2.9%였습니다. 게다가 2022년 국내 어류 총 생산량은 41억 8,200만 톤을 약간 웃돌아 2020년 41억 7,800만 톤에서 증가했습니다. 따라서 축산물에 대한 수요의 증대가 양 및 염소 수두 백신 시장 확대를 촉진할 것으로 예측됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Sheep and goat pox vaccines are specifically developed to prevent diseases caused by viruses belonging to the Capripoxvirus genus, which include sheep pox and goat pox. These vaccines play a critical role in preventing and managing outbreaks among sheep and goat populations, as both diseases can lead to significant economic losses due to high mortality rates and reduced productivity. They function by stimulating the immune system to generate antibodies against the viruses, thereby providing protection from infection.

The primary types of sheep and goat pox vaccines include live attenuated vaccines, inactivated vaccines, and others. Live attenuated vaccines use weakened forms of the virus to stimulate the immune system without causing severe illness. They are particularly effective for diseases such as sheep and goat pox where a robust immune response is necessary for effective protection. These vaccines are administered via various routes such as injectable and intranasal applications for sheep and goats.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The sheep and goat pox vaccines research report is one of a series of new reports from The Business Research Company that provides sheep and goat pox vaccines market statistics, including the sheep and goat pox vaccines industry's global market size, regional shares, competitors with a sheep and goat pox vaccines market share, detailed sheep and goat pox vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the sheep and goat pox vaccines industry. This sheep and goat pox vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sheep and goat pox vaccines market size has grown steadily in recent years. It will grow from $57.79 billion in 2024 to $60.43 billion in 2025 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to increased outbreaks of sheep and goat pox, government vaccination programs, advancements in veterinary medicine, high mortality rates in livestock, increased awareness among farmers, economic losses due to disease, trade restrictions on affected areas, improved diagnostic techniques, the historical prevalence of the disease, and collaboration between veterinary institutions.

The sheep and goat pox vaccines market size is expected to see steady growth in the next few years. It will grow to $71.37 billion in 2029 at a compound annual growth rate (CAGR) of 4.2%. The growth in the forecast period can be attributed to the growing demand for livestock products, expanding livestock farming, government subsidies for vaccines, rising investment in veterinary research, technological advancements in vaccine production, increasing awareness of animal health, international trade agreements, climate change impacting disease patterns, the emergence of new vaccine technologies, economic growth in developing regions. Major trends in the forecast period include the development of multivalent vaccines, increasing use of recombinant vaccines, growing focus on vaccine safety, rise in public-private partnerships, expansion of veterinary vaccine market, digital tracking of vaccination programs, increased funding for animal health research, regional disease eradication initiatives, growing adoption of sustainable farming practices, enhanced regulatory frameworks for vaccines.

The forecast of 4.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff-driven import delays in adjuvants and stabilizers essential for vaccine efficacy may affect disease prevention outcomes in small ruminants. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing demand for livestock products is poised to drive growth in the market for sheep and goat pox vaccines. Livestock products encompass various goods derived from domesticated animals raised in agricultural settings. This rising demand stems from factors such as income and population growth, urbanization, health considerations, evolving consumer preferences, globalization, trade, and economic development. Sheep and goat pox vaccines play a crucial role in protecting livestock products by preventing disease outbreaks and ensuring the health and productivity of sheep and goat populations. For example, in February 2024, the Department for Environment, Food, and Rural Affairs noted an increase in red meat production, particularly mutton and lamb, with the largest rise recorded at 2.9%. Additionally, total domestic fish production in 2022 slightly exceeded 4,182 million metric tons, up from 4,178 million metric tons in 2020. Hence, the growing demand for livestock products is expected to drive expansion in the sheep and goat pox vaccines market.

Major companies in the sheep and goat pox vaccine market are concentrating on the development of innovative products, such as live attenuated vaccines, to improve immune responses while minimizing side effects. Live attenuated vaccines contain live viruses or bacteria that have been weakened in the laboratory to prevent them from causing disease in healthy individuals. These vaccines stimulate a strong immune response by simulating a natural infection without causing illness. For example, in August 2022, the Indian Council of Agricultural Research, based in India, developed Lumpi-ProVacInd to fight Lumpy Skin Disease (LSD) in cattle. This vaccine is intended for preventive immunization, providing immunity for at least one year with a single dose that contains 103.5 TCID50 of the attenuated LSD virus. It is safe for animals, induces a strong immune response, and must be stored at 4°C, requiring careful handling during transportation and use.

In September 2022, Hester Biosciences Limited, an India-based animal healthcare company, acquired the manufacturing technology for the Goat Pox vaccine (Uttarkashi Strain) from the Indian Veterinary Research Institute (IVRI) for an undisclosed sum. This acquisition enables Hester to supply the goat pox vaccine through state government tenders for cattle immunization against lumpy skin disease in various states. The Indian Veterinary Research Institute, a prominent institution for livestock research and development in India, facilitated this technology transfer.

Major companies operating in the sheep and goat pox vaccines market are Indian Immunologicals Ltd., Kemin Industries, Bimeda Biologicals, Hester Biosciences Limited, Dollvet, MSD Animal Health, MCI Sante Animale, Creative Biolabs, Biovex Inc., Advacare Pharma, Brilliant Bio Pharma Private Limited, Intervac (PVT) Ltd., Agrinnovate India Limited, Bio-Med Pvt Limited, JOVAC, Vetal Animal Health Products, Kenya Veterinary Vaccines Production Institute, Vedall Pharma Private Limited, Farmer's Pharma Private Limited, Institute of Veterinary Biological Products

North America was the largest region in the sheep and goat pox vaccines market in 2024. The regions covered in the sheep and goat pox vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sheep and goat pox vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sheep and goat pox vaccines market consists of sales of recombinant vaccines and subunit vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sheep And Goat Pox Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sheep and goat pox vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for sheep and goat pox vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sheep and goat pox vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Sheep And Goat Pox Vaccines Market Characteristics

3. Sheep And Goat Pox Vaccines Market Trends And Strategies

4. Sheep And Goat Pox Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sheep And Goat Pox Vaccines Growth Analysis And Strategic Analysis Framework

6. Sheep And Goat Pox Vaccines Market Segmentation

7. Sheep And Goat Pox Vaccines Market Regional And Country Analysis

8. Asia-Pacific Sheep And Goat Pox Vaccines Market

9. China Sheep And Goat Pox Vaccines Market

10. India Sheep And Goat Pox Vaccines Market

11. Japan Sheep And Goat Pox Vaccines Market

12. Australia Sheep And Goat Pox Vaccines Market

13. Indonesia Sheep And Goat Pox Vaccines Market

14. South Korea Sheep And Goat Pox Vaccines Market

15. Western Europe Sheep And Goat Pox Vaccines Market

16. UK Sheep And Goat Pox Vaccines Market

17. Germany Sheep And Goat Pox Vaccines Market

18. France Sheep And Goat Pox Vaccines Market

19. Italy Sheep And Goat Pox Vaccines Market

20. Spain Sheep And Goat Pox Vaccines Market

21. Eastern Europe Sheep And Goat Pox Vaccines Market

22. Russia Sheep And Goat Pox Vaccines Market

23. North America Sheep And Goat Pox Vaccines Market

24. USA Sheep And Goat Pox Vaccines Market

25. Canada Sheep And Goat Pox Vaccines Market

26. South America Sheep And Goat Pox Vaccines Market

27. Brazil Sheep And Goat Pox Vaccines Market

28. Middle East Sheep And Goat Pox Vaccines Market

29. Africa Sheep And Goat Pox Vaccines Market

30. Sheep And Goat Pox Vaccines Market Competitive Landscape And Company Profiles

31. Sheep And Goat Pox Vaccines Market Other Major And Innovative Companies

32. Global Sheep And Goat Pox Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sheep And Goat Pox Vaccines Market

34. Recent Developments In The Sheep And Goat Pox Vaccines Market

35. Sheep And Goat Pox Vaccines Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기